InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Explore the detailed record of transactions filed by PATEL DINESH V PH D, Chief Executive Officer. Officer active across 1 companies, notably Protagonist Therapeutics, Inc. In total, 12 filings have been logged. Total volume traded: €855k. The latest transaction was disclosed on 12 May 2026 — Levée d'options. Regulator: SEC (Form 4). The full history is free.
Declarations12 total
US$1m75,000 shares@ US$18.38870.025% mcap70.7% of flow
Common Stock
SEC:0001104659-26-061476·
€1m75,000 shares@ €18.38870.025% mcap32.5% of flow
Common Stock
SEC:0001104659-26-061476:0·
€62,39015,742 shares@ €3.96330.0011% mcap1.5% of flow
Common Stock
SEC:0001104659-22-055995:0·
€118,66330,000 shares@ €3.95540.0022% mcap2.8% of flow
Common Stock
SEC:0001104659-22-050551:0·
€59,53734,087 shares@ €1.74660.0011% mcap1.4% of flow
Common Stock
SEC:0001104659-22-046158:0·
€100,9334,648 shares@ €21.71530.0018% mcap2.4% of flow
Common Stock
SEC:0001104659-22-029520:0·
031,250 shares0
Common Stock
SEC:0001104659-22-024835:0·
031,250 shares0
Common Stock
SEC:0001104659-22-024835·
€427,55015,000 shares@ €28.50330.0078% mcap21.9% of flow
Common Stock
SEC:0001104659-21-153135·
€427,55015,000 shares@ €28.50330.0078% mcap10.1% of flow
Common Stock
SEC:0001104659-21-153135:0·
€143,65040,000 shares@ €3.59130.0026% mcap7.4% of flow
Common Stock
SEC:0001104659-21-118054·
€143,65040,000 shares@ €3.59130.0026% mcap3.4% of flow
Common Stock
SEC:0001104659-21-118054:0·
12 of 12 declarations
About PATEL DINESH V PH D
Dinesh V. Patel, Ph.D. is the President and CEO of Protagonist Therapeutics, Inc. He leads the company in its strategic and operational activities, focusing on innovation in drug development. His expertise in the biopharmaceutical sector is essential for guiding the growth and development of Protagonist.
